We view the current market meltdown as being directly correlated with the increase in the average infection rate per infected person in the U.S.
The actions taken by the U.S. to date (“15 Days to Slow the Spread” and trillion-dollar stimulus) will not enough to slow the infection rate in our opinion.
Once investors have a clearer idea as to when a return to normalcy will occur, we believe the time will be right to buy certain non-profitable technology companies that have a strong balance sheet or balance sheet leveraged equities that are trading at low Price / Cash Flow multiplies.
You must be an Institutional Equity Research Subscriber to view the full graph, and more of our research on this topic